arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Sponsored Symposia

Friday 11 October 2019

15:30-16:30 Diagnostic workshop sponsored by

Program
Management of Invasive Candida Infections in critically ill patients: contribution of biomarkers

15:30 Invasive Candida infection in ICU patients: clinical aspects and Epidemiology
Garyphallia Poulakou, Sotiria General Hospital of Athens, Greece
15:45 discussion

15:50 Contribution of glycan biomarkers to the diagnosis of invasive Candidiasis
Boualem Sendid, Hospital Regional University Centre, Lille, France
16:05 discussion

16:10 Biomarker-based strategy for the early discontinuation of empirical anti-fungal treatment in ICU patients
Saad Nseir, Salengro Hospital, Hospital Regional University Centre, Lille, France
16:25 discussion

16:45-18:15 Integrated Symposium 1 sponsored by

Program
Prevention and Management of IFI – Mind the Gap(s)!

Chair: Prof Oliver A. Cornely,University Hospital of Cologne, Germany

16:45 Welcome Remarks
Oliver A. Cornely,University Hospital of Cologne, Germany

16:50 PK/PD Optimized Echinocandin Dosing
Russel E. Lewis, University of Bologna, Italy

17:05 Unmet Needs for Treatment of Invasive Candidiasis
Bart J. Kullberg,Radboud University Medical Center, The Netherlands

17:20 Rezafungin for Treatment of Invasive Candidiasis
George R. Thompson, University of California, Davis, USA

17:40 Current Challenges for Prophylaxis of Invasive Fungal Infections
Kieren A. Marr, Johns Hopkins University, USA

18:00 Panel Discussion

18:10 Closing Remarks
Oliver A. Cornely, University Hospital of Cologne, Germany

Saturday 12 October 2019

12:30-14:00 Integrated Symposium 2 sponsored by

Program
Tackling invasive mould disease, one patient at a time:
The value of a patient-tailored early treatment approach

12:30 Welcome and introduction
Johan Maertens, Hematologist, UZ Leuven, Belgium

12:35 Evolving risk stratification and empowering diagnostics to ensure targeted treatment
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria

12:55 Case study part 1
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria

13:00 Where are we now? Epidemiology, clinical data, guidelines and challenges in the invasive mould disease landscape  
Johan Maertens, Hematologist, UZ Leuven, Belgium

13:20 Case study part 2
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria 

13:25 PK/PD patient-considerations for the appropriate treatment of IMD
Federico Pea, MD, clinical pharmacologist in charge of chemotherapy at the Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital, Udine, Italy

13:45 Case study part 3
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria

13:50 – 14:00  Discussion, Questions & Answers and closure
Led by Johan Maertens, Hematologist, UZ Leuven, Belgium

Click here for a PDF version of the programme

18:00-19:30 Integrated Symposium 3 sponsored by

Program
Moulds on the march to the ICU

18:00 Introduction
Prof Malcolm Richardson, UK

18:05 Are there new risk factors in the ICU?
Prof Elie Azoulay, France

18:25 The search for predictive biomarkers
Prof Arnaldo Colombo, Brazil

18:50 Moulds in the non-neutropenic patient
Prof Matteo Bassetti, Italy

19:15 Q&A
All

 

Sunday 13 October 2019

12:30-13:00 Diagnostic symposium sponsored by 

Program
A new β-d-glucan assay for single tests

Moderator:
Stéphane Bretagne, MD, Professor of Medicine, head of the Parasitology-Mycology laboratories of the Saunt Louis University Hospital, Paris, France

Diagnosis of invasive fungal infections using a new ß-d-glucan assay for single-sample testing
Katrien Lagrou
, PharmD, PhD, Professor Faculty of Medicine, head of the Molecular Diagnostic Laboratory at the University Hospital of Leuven, Belgium, and the Belgian National Reference Center for Mycosis 

13:00-14:00 Diagnostic workshop sponsored by

Program
(1→3)-β-glucan in the diagnosis and clinical management of invasive fungal disease

Moderator:
Malcolm Richardson, PhD, FSB, FISSE, FRCPath, FECMM, Director and Consultant Clinical Scientist in Mycology – Manchester University NHS Foundation Trust,  Professor of Medical Mycology – University of Manchester, United Kingdom

 (1→3)-β-glucan in the diagnosis and clinical management of invasive fungal disease: From laboratory investigation to patient care
Thomas J. Walsh, MD
Professor of Medicine in Microbiology & Immunology,
Professor of Medicine in Pediatrics, Weill College of Medicine at Cornell University, New York, NY USA